The slip
PARKINSON RECEIPTno. 7361
23 Oct 2026, 08:31 UTColigodendrocytes, braak
predictionMMP16 in oligodendrocytes tracks Braak Lewy-body stage
registeredce85ff3fbeb1f7c7
discovery+0.05 p=0.894 n=9
replication-0.24 p=0.533 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.05, p 0.894)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT8ee42ec20ed9276db84ebd5a…
follows a31b43d04247…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7361: MMP16 in oligodendrocytes, braak
- power
- full sample -0.07 (p 0.787, n 18), 95% CI -0.52 to +0.41. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.09 (p 0.728, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.13 (p 0.609, n 18). could be the mix.
- skeptic
- leave-one-out range -0.17 to +0.06, sign flips 4; without severely affected donors -0.07 (p 0.787, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MMP16 in oligodendrocytes.
case closed: nothing better to follow up.